These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 25876785

  • 1. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome].
    Yamazaki H, Kondo T, Tatsumi G, Kotani S, Arai Y, Shirakawa K, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A.
    Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785
    [Abstract] [Full Text] [Related]

  • 2. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
    Usami M, Kuroda H, Yoshida M, Sakamoto H, Shimoyama S, Kanari Y, Yamada M, Abe T, Fujii S, Maeda M.
    Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment with recombinant thrombomodulin for B-cell lymphoma-associated hemophagocytic syndrome complicated by disseminated intravascular coagulation.
    Uni M, Yoshimi A, Maki H, Maeda D, Nakazaki K, Nakamura F, Fukayama M, Kurokawa M.
    Int J Clin Exp Pathol; 2013 Jun; 6(6):1190-4. PubMed ID: 23696942
    [Abstract] [Full Text] [Related]

  • 4. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
    Asakura H, Takahashi H, Tsuji H, Matsushita T, Ninomiya H, Honda G, Mimuro J, Eguchi Y, Kitajima I, Sakata Y.
    Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
    Ogura T, Eguchi T, Amano M, Sano T, Nishioka N, Miyano A, Tsujimae M, Tanimura H, Yamada T, Terashima Y, Okada A, Higuchi K.
    Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
    Ookura M, Hosono N, Tasaki T, Oiwa K, Fujita K, Ito K, Lee S, Matsuda Y, Morita M, Tai K, Negoro E, Kishi S, Iwasaki H, Ueda T, Yamauchi T.
    Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
    [Abstract] [Full Text] [Related]

  • 8. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
    Suetani K, Okuse C, Nakahara K, Michikawa Y, Noguchi Y, Suzuki M, Morita R, Sato N, Kato M, Itoh F.
    World J Gastroenterol; 2015 Jan 14; 21(2):533-40. PubMed ID: 25593469
    [Abstract] [Full Text] [Related]

  • 9. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T, Sugimori H, Kaku N, Tokuda K, Nagata T, Noda E, Morita M, Hashizume M, Maehara Y.
    Eur J Trauma Emerg Surg; 2015 Oct 14; 41(5):531-8. PubMed ID: 26038004
    [Abstract] [Full Text] [Related]

  • 10. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
    Kawano N, Tasaki A, Kuriyama T, Tahara Y, Yoshida S, Ono N, Himeji D, Yamashita K, Shibata Y, Goto T, Inoue T, Yokota-Ikeda N, Uezono S, Yuge A, Nishiguchi T, Kinjo T, Ogura Y, Beppu K, Ueda Y, Kinoshita M, Moritake H, Shimoda K, Ochiai H, Ueda A.
    Intern Med; 2014 Oct 14; 53(3):205-13. PubMed ID: 24492688
    [Abstract] [Full Text] [Related]

  • 11. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M, Minematsu Y, Fujii J, Mori K, Minato T, Miyagawa S, Fujimura R, Morikage N, Arata Y, Nakano C, Wada A, Ito T.
    Ther Apher Dial; 2013 Oct 14; 17(5):472-6. PubMed ID: 24107274
    [Abstract] [Full Text] [Related]

  • 12. [Treatment with recombinant thrombomodulin on disseminated intravascular coagulation caused by urinary tract infections; a retrospective comparative study with control cases].
    Machioka K, Shigehara K, Kadomoto S, Iwamoto H, Miyagi T, Nakashima T, Namiki M.
    Hinyokika Kiyo; 2015 Jan 14; 61(1):1-6. PubMed ID: 25656012
    [Abstract] [Full Text] [Related]

  • 13. Use of recombinant thrombomodulin in disseminated intravascular coagulation complicated hemophagocytic lymphohistiocytosis.
    Yamamoto M, Hori T, Hatakeyama N, Igarashi K, Inazawa N, Tsutsumi H, Suzuki N.
    Indian J Pediatr; 2014 Mar 14; 81(3):288-91. PubMed ID: 23912823
    [Abstract] [Full Text] [Related]

  • 14. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation.
    Itoh S, Shirabe K, Kohnoe S, Sadanaga N, Kajiyama K, Yamagata M, Anai H, Harimoto N, Ikegami T, Yoshizumi T, Maehara Y.
    Anticancer Res; 2016 May 14; 36(5):2493-6. PubMed ID: 27127163
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
    Morita N, Nakahara K, Morita R, Suetani K, Michikawa Y, Sato J, Tsuji K, Ikeda H, Matsunaga K, Watanabe T, Matsumoto N, Okuse C, Suzuki M, Itoh F.
    Intern Med; 2019 Apr 01; 58(7):907-914. PubMed ID: 30449812
    [Abstract] [Full Text] [Related]

  • 16. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study.
    Mitaka C, Kawagoe I, Satoh D, Hayashida M.
    Clin Appl Thromb Hemost; 2021 Apr 01; 27():10760296211050356. PubMed ID: 34859680
    [Abstract] [Full Text] [Related]

  • 17. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
    Kumura T, Aoyama Y, Ichihara H, Koh S, Mugitani A, Hayakawa H, Yukioka K, Kinoshita D, Nakagawa M, Yamazaki N.
    Rinsho Ketsueki; 2011 Feb 01; 52(2):68-72. PubMed ID: 21403426
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.